Basket | Login | Register


Karin reports about a meeting with a pharmaceutical company in Sweden

Wednesday 15 November 2017

A pharmaceutical company called AstraZeneca is testing a new drug for Alzheimer’s disease which is currently in Phase 3. The company wants to give more information about dementia and what it is like to live with the condition to their staff so they contacted Alzheimer Sweden and asked for a volunteer. My husband and I have volunteered to do this. We have already attended a preparatory meeting with two members of the company on 6 November at their head office in Göteborg/Mölndal. I will talk to the employees in mid-December about my experience of living with Alzheimer’s. Around 250-300 staff members will attend the meeting.